Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

110.28
-1.8800-1.68%
Volume:403.78K
Turnover:44.83M
Market Cap:5.43B
PE:-19.11
High:112.94
Open:111.15
Low:110.02
Close:112.16
Loading ...

Axsome Therapeutics Inc (AXSM) Q4 2024 Earnings Call Highlights: Robust Revenue Growth Amid ...

GuruFocus.com
·
19 Feb

Q4 2024 Axsome Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
19 Feb

Axsome Therapeutics Sees Robust Growth and Strategic Progress

TIPRANKS
·
19 Feb

Axsome Therapeutics’ Earnings Call: Growth Amid Challenges

TIPRANKS
·
19 Feb

Truist Securities Raises Price Target on Axsome Therapeutics to $200 From $190, Keeps Buy Rating

MT Newswires Live
·
19 Feb

Axsome Therapeutics: Strong Performance and Promising Pipeline Justify Buy Rating

TIPRANKS
·
19 Feb

Axsome Therapeutics (AXSM) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
19 Feb

Stock Track | Axsome Therapeutics Plummets 5.41% After Wider-Than-Expected Q4 Loss Despite Revenue Beat

Stock Track
·
18 Feb

Axsome Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
18 Feb

Axsome Therapeutics Q4 Loss Narrows, Revenue Rises

MT Newswires Live
·
18 Feb

Axsome Therapeutics reports Q4 EPS ($1.54), consensus ($1.00)

TIPRANKS
·
18 Feb

Axsome Therapeutics expects cash to fund operations into cash flow positivity

TIPRANKS
·
18 Feb

Axsome Therapeutics Revenue Surges 66%

Motley Fool
·
18 Feb

Axsome Therapeutics Q4 2024 GAAP EPS $(1.54) Misses $(1.03) Estimate, Sales $118.77M Beat $117.64M Estimate

Benzinga
·
18 Feb

Axsome Therapeutics: Sees Current Cash Sufficient to Fund Anticipated Operations Into Cash Flow Positivity

THOMSON REUTERS
·
18 Feb

Axsome Therapeutics Inc: Total Q4 Net Product Revenue of $118.8 Mln

THOMSON REUTERS
·
18 Feb

Axsome Therapeutics Inc: Nda Submission for Encore Anticipated in 2H 2025

THOMSON REUTERS
·
18 Feb

BRIEF-Axsome Therapeutics Q4 Net Income USD -74.912 Million

Reuters
·
18 Feb

Axsome Therapeutics Q4 Operating Expenses USD 191.383 Million

THOMSON REUTERS
·
18 Feb

Axsome Therapeutics Q4 Pretax Profit USD -74.827 Million

THOMSON REUTERS
·
18 Feb